Initiated VALUE, a global Phase III pivotal trial of EscharEx® for venous leg ulcers Expanded strategic research collaborations with industry leaders, now including Kerecis $20 million in revenue for ...

During the year, Hemisphere also distributed over $21 million in shareholder returns, made up of $15.7 million in base and special dividends and $5.5 million of share purchases under its normal course ...

Initiated VALUE, a global Phase III pivotal trial of EscharEx® for venous leg ulcersExpanded strategic research collaborations with industry ...

Strong Holistic Margin Management Productivity Savings and Expected Incremental Cost Efficiency Initiatives to Fuel Increased ...

Guidance for 2025Announces $3 Million Share Repurchase Program SUMMIT, N.J., March 18, 2025 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) ("Aterian" or the "Company"), a technology-enabled ...

In Cuba, the skyrocketing cost of pork has delivered a significant blow to the regime, laying bare the ineffectiveness of ...

The Company expects 2025 annual Adjusted EBITDA to be essentially break-even compared to an Adjusted EBITDA loss of $ (2.1) million in 2024, reflecting the success of the Company’s business ...